Literature DB >> 7639337

Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.

L Gabriele1, T Kaido, D Woodrow, J Moss, M Ferrantini, E Proletti, L Santodonato, C Rozera, C Maury, F Belardelli.   

Abstract

DBA/2 mice were injected subcutaneously with an interferon (IFN)-alpha/beta-resistant line of Friend erythroleukemia cells (FLC) transfected with the mouse IFN-alpha 1 gene. These tumor cells produced IFN constitutively, and mice had persistently high levels of IFN in the circulation. We examined the IFN-induced host mechanisms responsible for the local inhibition of growth of these IFN-alpha-transfected FLC and some of the unusual systemic effects of constant interferonemia such as extramedullary hematopoiesis in the liver, an increase in myeloid cells in the spleen, and persistently elevated splenic natural killer (NK) cell activity. In addition, both DBA/2 +/bg and beige mice developed a rapid and specific resistance to intravenous challenge with parental FLC. In previous experiments DBA/2 beige mice could not be protected by exogenous IFN-alpha/beta. The differences in the response of mice to the constitutive production of IFN-alpha by IFN-alpha-transfected tumor cells and their response to exogenous IFN is discussed in terms of the effects of IFN on the host and of antitumor therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639337      PMCID: PMC1869831     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis.

Authors:  S B Lee; M Esteban
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

Review 2.  Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

Authors:  M P Colombo; G Forni
Journal:  Immunol Today       Date:  1994-02

3.  Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.

Authors:  H Hock; M Dorsch; U Kunzendorf; Z Qin; T Diamantstein; T Blankenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

4.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

Authors:  H F Dvorak; I Gresser
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

6.  Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.

Authors:  A R Miller; W H McBride; S M Dubinett; G J Dougherty; J D Thacker; H Shau; D B Kohn; R C Moen; M J Walker; R Chiu
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

7.  Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.

Authors:  P L Lollini; M C Bosco; F Cavallo; C De Giovanni; M Giovarelli; L Landuzzi; P Musiani; A Modesti; G Nicoletti; G Palmieri
Journal:  Int J Cancer       Date:  1993-09-09       Impact factor: 7.396

8.  Interleukin-2 gene transfer into murine neuroblastoma decreases tumorigenicity and enhances systemic immunity causing regression of preestablished retroperitoneal tumors.

Authors:  E Katsanis; P J Orchard; M A Bausero; K B Gorden; R S McIvor; B R Blazar
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1994-02

9.  Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.

Authors:  T Kaido; I Gresser; C Maury; M T Maunoury; F Vignaux; F Belardelli
Journal:  Int J Cancer       Date:  1993-05-28       Impact factor: 7.396

10.  Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.

Authors:  A Stoppacciaro; C Melani; M Parenza; A Mastracchio; C Bassi; C Baroni; G Parmiani; M P Colombo
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  1 in total

1.  Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha: differential effects on tumorigenicity and host response.

Authors:  C Rozera; D Carlei; P L Lollini; C De Giovanni; P Musiani; E Di Carlo; F Belardelli; M Ferrantini
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.